.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
here are 4 mass. biotechs making noise at the ash conference so far
.
a grand jury report following the worst outbreak of
.
on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation.
.